Genetic or pharmacological inactivation of GSK-3β reduces Aβ and its associated toxicity, ameliorates Aβ-induced behavioral deficits, and rescues neuronal loss in AD mouse models60, 61, 62. The gene discussed is GSK3B; the disease is Alzheimer disease.